Practices in larger metros, those with multiple providers, or those integrating high-value ancillary services like hormone optimization therapy frequently exceed these figures
As these drugs become more widely used for weight loss and metabolic conditions, clinicians and individuals alike are grappling with questions about how appetite-suppressing medications intersect with disordered eating patterns, body image concerns and recovery
FDA Adverse Event Reporting System (FAERS) data may include reports of musculoskeletal symptoms in patients using GLP-1 receptor agonists, though these reports do not establish causation and may reflect coincidental timing rather than a true drug effect
Skin feels stronger, more comfortable, and better protected.
The Today Show story also cited a research letter published in JAMA (formerly the Journal of the American Medical Association) warning of an increased risk of severe stomach problems for people taking GLP-1 agonists such as Ozempic and Wegovy
These advancements are particularly significant for enhancing solubility and bioavailability [203]
